tyrphostin ag1478
Recently Published Documents


TOTAL DOCUMENTS

11
(FIVE YEARS 0)

H-INDEX

6
(FIVE YEARS 0)

Author(s):  
Gaelle Boncompain ◽  
Nelly Gareil ◽  
Sarah Tessier ◽  
Aurianne Lescure ◽  
Thouis R. Jones ◽  
...  

2016 ◽  
Vol 60 (10) ◽  
pp. 6402-6406 ◽  
Author(s):  
Cristina M. Dorobantu ◽  
Christian Harak ◽  
Rahel Klein ◽  
Lonneke van der Linden ◽  
Jeroen R. P. M. Strating ◽  
...  

ABSTRACTEncephalomyocarditis virus (EMCV), like hepatitis C virus (HCV), requires phosphatidylinositol 4-kinase IIIα (PI4KA) for genome replication. Here, we demonstrate that tyrphostin AG1478, a known epidermal growth factor receptor (EGFR) inhibitor, also inhibits PI4KA activity, bothin vitroand in cells. AG1478 impaired replication of EMCV and HCV but not that of an EMCV mutant previously shown to escape PI4KA inhibition. This work uncovers novel cellular and antiviral properties of AG1478, a compound previously regarded only as a cancer chemotherapy agent.


2012 ◽  
Vol 46 (11) ◽  
pp. 1393-1405 ◽  
Author(s):  
Yang Yu ◽  
Si-Miao Fan ◽  
Yuan-Chao Ye ◽  
Shin-ichi Tashiro ◽  
Satoshi Onodera ◽  
...  

2011 ◽  
Vol 82 (11) ◽  
pp. 1583-1592 ◽  
Author(s):  
Laia Caja ◽  
Patricia Sancho ◽  
Esther Bertran ◽  
Conrad Ortiz ◽  
Jean S. Campbell ◽  
...  

2009 ◽  
Vol 3 (5) ◽  
pp. 454-460
Author(s):  
K. A. Kondratov ◽  
A. L. Chernorudskiy ◽  
A. P. Amosova ◽  
E. S. Kornilova

2005 ◽  
Vol 342 (2) ◽  
pp. 292-299 ◽  
Author(s):  
Andrew H.A. Clayton ◽  
Matthew A. Perugini ◽  
Janet Weinstock ◽  
Julie Rothacker ◽  
Keith G. Watson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document